Amgen Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amgen (AMGN) Tops Q2 EPS by 41c, Issues In-Line Guidance
July 28, 2020 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $4.25, $0.41 better than the analyst estimate of $3.84. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.18 billion.
GUIDANCE:
Amgen sees FY2020 EPS of $15.10-$15.75, versus the consensus of $15.64. Amgen sees... More
